Insider Trading disclosures for Neuphoria Therapeutics Inc.
The latest disclosure was made by Peter Miles Davies in Neuphoria Therapeutics Inc. where a trade of 6,783
Restricted Stock Units done
was reported to US exchanges on April 16, 2025.
Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Client Name |
Client Category |
Action |
Reported to Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Security Type |
|
Peter Miles Davies
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Apr 2025 |
6,783 |
6,783
|
-
|
|
-
|
Restricted Stock Units |
|
Alan Fisher
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Apr 2025 |
13,566 |
13,658
|
-
|
|
-
|
Restricted Stock Units |
|
Jane Ryan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Apr 2025 |
6,783 |
7,013
|
-
|
|
-
|
Restricted Stock Units |
|
David Wilson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Apr 2025 |
6,783 |
6,875
|
-
|
|
-
|
Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges